Eli Lilly and (LLY) Revenue — Quarter Ended Mar 31, 2026
Revenue for the current reporting period increased compared to the same period one year earlier, continuing a trend of strong year-over-year growth. Sequentially, revenue also rose from the preceding three-month period.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for the current reporting period increased compared to the same period one year earlier, continuing a trend of strong year-over-year growth. Sequentially, revenue also rose from the preceding three-month period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$19.8B
Revenue reported for this quarter.
Quarter-over-quarter
+2.6%
Change from the immediately preceding quarter.
Year-over-year
+55.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$72.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $15.6B | +37.6% |
| Sep 30, 2025 | $17.6B | +53.9% |
| Dec 31, 2025 | $19.3B | +42.6% |
| Mar 31, 2026 | $19.8B | +55.5% |
Revenue performance
Revenue in the current period grew both sequentially and year over year. The year-over-year increase remained substantial, while the sequential change was more moderate.
Quarterly comparison
Compared to the immediately preceding three-month period, revenue rose at a slower pace. Year-over-year growth has been robust over recent comparable periods.
What to watch
The pace of sequential revenue change will be a key factor to observe in upcoming periods.